Nussbaum Ran 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:08 am Unchanged | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Nussbaum Ran | 44,643 4.960% | 0 (Unchanged) | Filing |
| 2021-02-16 07:31 am Purchase | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Nussbaum Ran | 44,643 6.400% | 44,643 (New Position) | Filing |